Fayez Sarofim & Co’s NanoViricides NNVC Stock Holding History

Fayez Sarofim & Co’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,429	Closed	-$7K	–	257
2019 Q2	$7K	Hold	1,429	–	–	﹤0.01%	253
2019 Q1	$8K	Hold	1,429	–	–	﹤0.01%	248
2018 Q4	$6K	Hold	1,429	–	–	﹤0.01%	238
2018 Q3	$10K	Hold	1,429	–	–	﹤0.01%	241
2018 Q2	$13K	Hold	1,429	–	–	﹤0.01%	245
2018 Q1	$24K	Hold	1,429	–	–	﹤0.01%	248
2017 Q4	$25K	Hold	1,429	–	–	﹤0.01%	248
2017 Q3	$33K	Hold	1,429	–	–	﹤0.01%	243
2017 Q2	$39K	Hold	1,429	–	–	﹤0.01%	243
2017 Q1	$32K	Sell	1,429 -1,428	-50%	-$33.3K	﹤0.01%	245
2016 Q4	$61K	Buy	2,857 +1,428	+100%	+$38.1K	﹤0.01%	241
2016 Q3	$48K	Hold	1,429	–	–	﹤0.01%	245
2016 Q2	$46K	Hold	1,429	–	–	﹤0.01%	241
2016 Q1	$63K	Buy	+1,429	New	+$55.5K	﹤0.01%	244

Other funds holding NNVC

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fayez Sarofim & Co's NNVC Position: Q3 2019 in Review

Fayez Sarofim & Co sold out of NanoViricides (NNVC) in Q3 2019, closing a stake of 1,429 shares — an estimated $7K sold.

Fayez Sarofim & Co first reported a position in NNVC in Q1 2016 and held it in 14 quarters. The position peaked at $63K in Q1 2016. 17 funds tracked by Wall St. Rank hold NNVC as of Q3 2019.

Fayez Sarofim & Co reported no remaining NanoViricides position as of Q3 2019 after selling out during the quarter.
Fayez Sarofim & Co sold 1,429 NanoViricides shares in Q3 2019, an estimated $7K.
Fayez Sarofim & Co first reported a position in NanoViricides in Q1 2016 and held it in 14 quarters.
Fayez Sarofim & Co's NanoViricides position peaked at $63K in Q1 2016.
17 funds tracked by Wall St. Rank held NanoViricides as of Q3 2019.

Based on Fayez Sarofim & Co's 13F filing for Q3 2019, filed 13 Nov 2019.